Novavax12 Mar 2021 09:58
Cepi backed Novavax last year, whose trial results were released last night, were worth £350m which is equivalent to us being about 40p. Within months their market cap went to around £17bn, before falling to £10bn. These are obviously life changing numbers for most on here. I have no idea what they do apart from Covid and we know have immunibody and moditope and all the rest. In other words Novavax were very similar to us last year, albeit on Nasdaq and yes you could quite rightly argue I should start my sums at 5p. Is anyone else doing similar sums with what we now know with Cepi etc.